UTHR

#499
United Therapeutics Corp
578.63 USD
+0.17%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
578.54
581.42
Rango anual
272.17
607.89
Cambio diario
+0.17%
Variación mensual
+7.81%
Variación en los últimos 6 meses
+33.50%
Cambio anual
+103.56%
Cierres anteriores
577.63
Abrir
580.13
Bid
Ask
Mínimo
578.54
High
581.42
Volumen
130
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 25.36 B
  • Employee 1 400
  • Founded 1996
  • CEO N/A
  • Website www.unither.com
  • Headquarter Delaware, United States
  • FIGI BBG000BV4XJ1
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
17.49
Relación precio/flujo de caja
7.33

United Therapeutics Corporation - Common Stock

United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.

Noticias